These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Prevalence of primary aldosteronism among Asian hypertensive patients in Singapore. Loh KC; Koay ES; Khaw MC; Emmanuel SC; Young WF J Clin Endocrinol Metab; 2000 Aug; 85(8):2854-9. PubMed ID: 10946893 [TBL] [Abstract][Full Text] [Related]
3. Primary aldosteronism in a general population sample. The Czech post-MONICA study. Widimský J; Bruthans J; Wohlfahrt P; Krajčoviechová A; Šulc P; Linhart A; Filipovský J; Lánská V; Cífkova R Blood Press; 2020 Jun; 29(3):191-198. PubMed ID: 32036692 [No Abstract] [Full Text] [Related]
4. Comparison between screening for primary aldosteronism with and without drug adjustment. Hua Y; He Q Blood Press; 2024 May; 33(1):2350981. PubMed ID: 38824645 [TBL] [Abstract][Full Text] [Related]
5. Prevalence of primary aldosteronism among unselected hypertensive patients: a prospective study based on the use of an aldosterone/renin ratio above 25 as a screening test. Fogari R; Preti P; Zoppi A; Rinaldi A; Fogari E; Mugellini A Hypertens Res; 2007 Feb; 30(2):111-7. PubMed ID: 17460380 [TBL] [Abstract][Full Text] [Related]
6. [Aldosterone/renin ratio in the diagnosis of primary aldosteronism]. Ríos MC; Izquierdo A; Sotelo M; Honnorat E; Rodríguez Cuimbra S; Catay E; Popescu BM Medicina (B Aires); 2011; 71(6):525-30. PubMed ID: 22167725 [TBL] [Abstract][Full Text] [Related]
7. [Aldosterone-to-renin ratio threshold for screening primary aldosteronism in Chinese hypertensive patients]. Chen SX; Du YL; Zhang J; Gong YC; Hu YR; Chu SL; He QB; Song YY; Zhu DL Zhonghua Xin Xue Guan Bing Za Zhi; 2006 Oct; 34(10):868-72. PubMed ID: 17217708 [TBL] [Abstract][Full Text] [Related]
8. Normokalemic hyperaldosteronism in patients with resistant hypertension. Benchetrit S; Bernheim J; Podjarny E Isr Med Assoc J; 2002 Jan; 4(1):17-20. PubMed ID: 11802302 [TBL] [Abstract][Full Text] [Related]
9. Screening for primary aldosteronism in hypertensive subjects: results from two German epidemiological studies. Hannemann A; Bidlingmaier M; Friedrich N; Manolopoulou J; Spyroglou A; Völzke H; Beuschlein F; Seissler J; Rettig R; Felix SB; Biffar R; Döring A; Meisinger C; Peters A; Wichmann HE; Nauck M; Wallaschofski H; Reincke M Eur J Endocrinol; 2012 Jul; 167(1):7-15. PubMed ID: 22495491 [TBL] [Abstract][Full Text] [Related]
10. Determining the Prevalence of Primary Aldosteronism in Patients With New-Onset Type 2 Diabetes and Hypertension. Hu Y; Zhang J; Liu W; Su X J Clin Endocrinol Metab; 2020 Apr; 105(4):. PubMed ID: 32163576 [TBL] [Abstract][Full Text] [Related]
11. Clinical characteristics of primary aldosteronism screened from Chinese patients with hypertension: The China primary aldosteronism prospective study. Hu Z; Chen X; Cheng YB; Zhong P; Li QA; Zhao Y; Luan H; Ren J; Chen GL; Wang JG J Clin Hypertens (Greenwich); 2024 Sep; 26(9):1082-1089. PubMed ID: 39037171 [TBL] [Abstract][Full Text] [Related]
12. Predictors of confirmatory test results for the diagnosis of primary hyperaldosteronism in hypertensive patients with an aldosterone-to-renin ratio greater than 20. The SHRIMP study. Okamoto R; Taniguchi M; Onishi Y; Kumagai N; Uraki J; Fujimoto N; Fujii E; Yano Y; Ogura T; Ito M Hypertens Res; 2019 Jan; 42(1):40-51. PubMed ID: 30401909 [TBL] [Abstract][Full Text] [Related]
13. Prevalence of primary aldosteronism without hypertension in the general population: Results in Shika study. Karashima S; Kometani M; Tsujiguchi H; Asakura H; Nakano S; Usukura M; Mori S; Ohe M; Sawamura T; Okuda R; Hara A; Takamura T; Yamagishi M; Nakamura H; Takeda Y; Yoneda T Clin Exp Hypertens; 2018; 40(2):118-125. PubMed ID: 28723305 [TBL] [Abstract][Full Text] [Related]
14. High prevalence of primary aldosteronism in the Tayside hypertension clinic population. Lim PO; Dow E; Brennan G; Jung RT; MacDonald TM J Hum Hypertens; 2000 May; 14(5):311-5. PubMed ID: 10822317 [TBL] [Abstract][Full Text] [Related]
15. Comparisons of plasma aldosterone and renin data between an automated chemiluminescent immunoanalyzer and conventional radioimmunoassays in the screening and diagnosis of primary aldosteronism. Tamura N; Watanabe E; Shirakawa R; Nakatani E; Yamada K; Hatakeyama H; Torii-Hanakita M; Kyo C; Kosugi R; Ogawa T; Kotani M; Usui T; Inoue T PLoS One; 2021; 16(7):e0253807. PubMed ID: 34242264 [TBL] [Abstract][Full Text] [Related]
16. The captopril challenge test for diagnosing primary Aldosteronism in a Chinese population. Zhu KY; Zhang Y; Zhang WJ; Li HY; Feng WH; Zhu DL; Li P BMC Endocr Disord; 2019 Jun; 19(1):65. PubMed ID: 31234846 [TBL] [Abstract][Full Text] [Related]
17. Screening for primary aldosteronism in an argentinian population: a multicenter prospective study. Leal Reyna M; Gómez RM; Lupi SN; Belli SH; Fenili CA; Martínez MS; Ruibal GF; Rossi MA; Chervin RA; Cornaló D; Contreras LN; Costa L; Nofal MT; Damilano SA; Pardes EM Arch Endocrinol Metab; 2015 Oct; 59(5):441-7. PubMed ID: 26222233 [TBL] [Abstract][Full Text] [Related]
18. High prevalence of primary aldosteronism using postcaptopril plasma aldosterone to renin ratio as a screening test among Italian hypertensives. Rossi E; Regolisti G; Negro A; Sani C; Davoli S; Perazzoli F Am J Hypertens; 2002 Oct; 15(10 Pt 1):896-902. PubMed ID: 12372677 [TBL] [Abstract][Full Text] [Related]
19. Active renin versus plasma renin activity to define aldosterone-to-renin ratio for primary aldosteronism. Ferrari P; Shaw SG; Nicod J; Saner E; Nussberger J J Hypertens; 2004 Feb; 22(2):377-81. PubMed ID: 15076197 [TBL] [Abstract][Full Text] [Related]
20. The aldosterone/renin ratio as a screening test for primary aldosteronism. Rayner BL; Opie LH; Davidson JS S Afr Med J; 2000 Apr; 90(4):394-400. PubMed ID: 10957926 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]